SD Biotechnologies Co., Ltd.

A217480

KR7217480003

Personal Products

End-of-day quote Korea S.E. Other stock markets 04:30:00 22/03/2023 am IST			5-day change	1st Jan Change
500 ^KRW	-4.90%		+0.00%	+0.00%

2023	SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023	CI
2023	SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd.	CI

SD Biotechnologies Co., Ltd. announced that it has received KRW 17 billion in funding from BNK Securities Co., Ltd.

June 18, 2021

On June 18, 2021, SD Biotechnologies Co., Ltd. (KOSDAQ:A217480) closed the transaction.

Latest news about SD Biotechnologies Co., Ltd.

SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023	24/23/24	CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd.	27/23/27	CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 11.999999918 billion in funding	26/23/26	CI
SD Biotechnologies Co., Ltd. agreed to acquire a 38.636208% stake in IMMUNOBIOTECH Corp. from KOSSEN Co., Ltd. for KRW 5.3 billion.	19/22/19	CI
SD Biotechnologies to Raise $27 Million From Share Sale; Shares Slump 23%	16/22/16	MT
SD Biotechnologies Co., Ltd. Auditor Raises 'Going Concern' Doubt	21/22/21	CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 17 billion in funding from BNK Securities Co., Ltd.	18/21/18	CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 17000 billion in funding from BNK Securities Co., Ltd. and other investors	16/21/16	CI
SD Biotechnologies Co., Ltd. announced that it has received KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd.	30/20/30	CI
SD Biotechnologies Co., Ltd. announced that it expects to receive KRW 21 billion in funding from Leading Investment & Securities Co., Investment Arm, EBEST Investment & Securities Co., Ltd.	28/20/28	CI
SD Biotechnologies Co., Ltd. cancelled the acquisition of remaining 5.59% stake in Alpha B&H Co.,Ltd.	30/20/30	CI
SD Biotechnologies Co., Ltd. agreed to acquire remaining 5.59% stake in Alpha B&H Co.,Ltd for KRW 45.7 million.	30/19/30	CI
SD Biotechnologies Co., Ltd. has completed an IPO in the amount of KRW 57.6 billion.	24/17/24	CI
SD Biotechnologies Co., Ltd. has filed an IPO.	03/16/03	CI

Chart SD Biotechnologies Co., Ltd.

Duration

Period

More charts

SD BIOTECHNOLOGIES CO., LTD. is a Korea-based company principally engaged in manufacture and distribution of cosmetics. The Companyâs products include basic skin care products and mask pack. The Company distributes its products within the domestic market and to overseas markets

Sector

Personal Products

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SD BIOTECHNOLOGIES CO., LTD.	+0.00%	1.09Cr
L'ORÉAL	+1.39%	26TCr
KAO CORPORATION	+17.12%	2.04TCr
GALDERMA GROUP AG	0.00%	1.83TCr
SHISEIDO COMPANY, LIMITED	+11.57%	1.19TCr
COTY INC.	-11.84%	969.38Cr
AMOREPACIFIC CORPORATION	+16.55%	757.54Cr
PROYA COSMETICS CO.,LTD.	+13.64%	610.39Cr
NATURA &CO HOLDING S.A.	-6.69%	465.75Cr
INTERPARFUMS	-3.17%	361.07Cr

Cosmetics & Perfumes

SD Biotechnologies Co., Ltd.

Equities

A217480

KR7217480003

Personal Products

SD Biotechnologies Co., Ltd. announced that it has received KRW 17 billion in funding from BNK Securities Co., Ltd.

Latest news about SD Biotechnologies Co., Ltd.

Chart SD Biotechnologies Co., Ltd.

Company Profile

Income Statement Evolution

Sector Cosmetics & Perfumes